Basket cover image
15 handpicked stocks

Silver Tsunami Solvers

Tap into companies serving the growing senior population's health, housing, and lifestyle needs. These carefully selected stocks represent businesses positioned to benefit from the substantial and increasing purchasing power of older demographics.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juin 18

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

HCSG

Healthcare Services Group Inc

HCSG

Current price

$15.39

This company provides essential housekeeping and dietary services specifically for the healthcare and senior living industry.

BKD

Brookdale Senior Living Inc.

BKD

Current price

$7.19

As a premier operator of senior living communities, this company directly addresses the housing needs of the aging population.

ENSG

Ensign Group Inc

ENSG

Current price

$167.02

It offers a comprehensive suite of services for seniors, including skilled nursing, senior living facilities, and rehabilitative care.

About This Group of Stocks

1

Our Expert Thinking

We've identified companies benefiting from one of the most reliable demographic trends: global aging. The baby boomer generation and those following represent an enormous market with significant financial resources and non-discretionary spending needs in healthcare, housing, and services.

2

What You Need to Know

These stocks span various industries including senior housing operators, healthcare REITs, home medical equipment, and end-of-life services. They provide exposure to a powerful long-term trend, with many offering dividend income potential alongside growth possibilities.

3

Why These Stocks

Each company was selected for its direct involvement in the senior care ecosystem. We've balanced established market leaders with innovative providers advancing the shift toward home-based care models and telehealth—developments that are expanding the market for senior-focused services.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+141.88%

Group Performance Snapshot

141.88%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 141.88% over the next year.

9 of 14

Stocks Rated Buy by Analysts

9 of 14 assets in this group are rated Buy by professional analysts.

10.7% vs 4%

Group Growth vs Bank interest

This group averaged a 10.7% return last month, beating the typical 4% bank rate.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

👵

Riding the Age Wave

Baby boomers are entering retirement at a rate of 10,000 per day, creating massive demand for senior-focused services that isn't slowing down anytime soon.

🏠

The Home Care Revolution

New technologies are transforming how seniors receive care, creating exciting investment opportunities in companies enabling the shift to more desirable and cost-effective home-based services.

💰

Recession-Resistant Potential

Many services for seniors are essential and non-discretionary, potentially offering more stability during economic downturns compared to consumer discretionary sectors.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.